Drugs / Probiotic Blend Capsule
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06579066 | Sep 2024 → Feb 2025 overdue | chronic kidney disease | Ain Shams University | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Probiotic Blend Capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06579066 ↗ |
| Modality | Other / unclassified | “Probiotics are defined as live microorganisms that consumed in adequate amounts; confer a health effect on the host.” NCT06579066 ↗ |